Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
FOMX was delisted on the 6th of March, 2020.
58 hedge funds and large institutions have $68.5M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 10 closing their positions.
6% less funds holding
Funds holding: 62 → 58 (-4)
15% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 20
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
40% less capital invested
Capital invested by funds: $115M → $68.5M (-$46.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DA
DSC Advisors
Chicago,
Illinois
|
+$1.17M |
| 2 |
Renaissance Technologies
New York
|
+$915K |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$847K |
| 4 |
DAM
DLD Asset Management
New York
|
+$672K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$526K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Handelsbanken Fonder
Stockholm,
Sweden
|
-$2.55M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$2.36M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.75M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$1.66M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$675K |
FOMX Hedge Fund Activity: Q2 2019 in Review
58 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q2 2019, worth a combined $68.5M — down 40% from $115M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of FOMX and 6 opened new positions — a net loss of 4 holders — while 20 trimmed existing stakes and 17 added.
The largest buyer was DSC Advisors, adding an estimated $1.17M. The largest seller was Handelsbanken Fonder, exiting entirely with an estimated $2.55M sold.
- 58 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q2 2019, down from 62 in Q1 2019.
- Funds reported $68.5M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q2 2019, down 40% quarter-over-quarter.
- 6 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q2 2019 and 10 closed out, a net change of -4 holders.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q2 2019 was DSC Advisors, an estimated $1.17M added.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q2 2019 was Handelsbanken Fonder, an estimated $2.55M sold.
Based on aggregated 13F filings for Q2 2019.